Home/Filings/4/A/0001437749-17-012084
4/A//SEC Filing

Diffusion Pharmaceuticals Inc. 4/A

Accession 0001437749-17-012084

$CRVOCIK 0001053691operating

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 4:02 PM ET

Size

5.6 KB

Accession

0001437749-17-012084

Insider Transaction Report

Form 4/AAmended
Period: 2017-05-10
Gainer John
DirectorChief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-05-10+34,00034,000 total
    Exercise: $2.96Exp: 2027-05-10Common Stock (34,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on May 31, 2020.

Documents

1 file

Issuer

Diffusion Pharmaceuticals Inc.

CIK 0001053691

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001053691

Filing Metadata

Form type
4/A
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:02 PM ET
Size
5.6 KB